Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thyroid-stimulating Immunoglobulins Level in Patients With Graves' Disease Undergoing Maintenance-dose of Antithyroid Drug and Its Relationship With Disease Relapse

NCT05713097 is registered in ClinicalTrials.gov with University of Medicine and Pharmacy at Ho Chi Minh City as lead sponsor.

NCT NCT05713097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05713097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thyroid-stimulating Immunoglobulins Level in Patients With Graves' Disease Undergoing Maintenance-dose of Antithyroid Drug and Its Relationship With Disease Relapse
Lead sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Phase
Observational
Overall status
Completed
Start date
January 2, 2022
Completion date
August 31, 2022
Enrollment
352 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti-thyroid antibodies disorder, graves disease, immunoglobulin